Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.85
Merlin, Inc. issued 9,803,922 shares of New Merlin Labs Preferred Stock and a Closing Warrant to purchase a number of shares of New Merlin Labs Common Stock equal to the amount of of convertible note to accredited investors (Closing PIPE Investor and Additional Closing PIPE Investors) for aggregate purchase price of $100,000,000 (increase from $50,000,000) for the Closing PIPE Investment; aggregate purchase price for Additional Closing PIPE Inves.
- Security
- convertible note
- Shares
- 9,803,922 shares of New Merlin Labs Preferred Stock and a Closing Warrant to purchase a number of shares of New Merlin Labs Common Stock equal to the amount of
- Purchaser
- accredited investors (Closing PIPE Investor and Additional Closing PIPE Investors)
- Consideration
- aggregate purchase price of $100,000,000 (increase from $50,000,000) for the Closing PIPE Investment; aggregate purchase price for Additional Closing PIPE Inves
Exact text from the filing
On November 17, 2025, Inflection Point and Merlin Labs entered into an amendment to the Closing PIPE Subscription Agreement with the Closing PIPE Investor (“ Amendment No. 1 to the Closing PIPE Subscription Agreement ”), pursuant to which the Closing PIPE Investor agreed to increase its Closing PIPE Investment to $100,000,000, for which it will receive 9,803,922 shares of New Merlin Labs Preferred Stock and a Closing Warrant to purchase a number of shares of New Merlin Labs Common Stock equal to the amount of shares into which such shares of New Merlin Labs Common Stock underlying the New Merlin Labs Preferred Stock are initially convertible, on the same terms and conditions as the Closing PIPE Subscription Agreement.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.85
Merlin, Inc. issued 1,666,668 shares of New Merlin Labs Preferred Stock and Closing Warrants to purchase a number of shares of New Merlin Labs Common Stock that is equal to 75% of of convertible note to Additional Closing PIPE Investors for aggregate purchase price not specified.
- Security
- convertible note
- Shares
- 1,666,668 shares of New Merlin Labs Preferred Stock and Closing Warrants to purchase a number of shares of New Merlin Labs Common Stock that is equal to 75% of
- Purchaser
- Additional Closing PIPE Investors
- Consideration
- aggregate purchase price not specified
Exact text from the filing
Inflection Point and Merlin Labs also entered into Securities Purchase Agreements, dated November 17, 2025 (the “ Additional Closing PIPE Subscription Agreements ”), with certain accredited investors signatory thereto (the “ Additional Closing PIPE Investors ”), pursuant to which, among other things, the Additional Closing PIPE Investors agreed to purchase, and Inflection Point agreed to sell, an aggregate of 1,666,668 shares of New Merlin Labs Preferred Stock and Closing Warrants to purchase a number of shares of New Merlin Labs Common Stock that is equal to 75% of the amount of shares into which such shares of New Merlin Labs Common Stock underlying the New Merlin Labs Preferred Stock are initially convertible, in a private placement, on substantially the same terms as the Closing PIPE Subscription Agreement
View on SEC.gov